This site is intended for healthcare professionals only
LoginRegister
small cell lung cancer treatmentGilead Sciences earns USFDA Breakthrough Therapy Designation for lung cancer treatment Trodelvy
Precigen secures full USFDA nod for Papzimeos for adults with Recurrent Respiratory PapillomatosisJnJ seeks USFDA approval for Simponi to treat pediatric ulcerative colitis
USFDA accepts Merck application for RSV treatmentMerck application for RSV treatment Clesrovimab for infants accepted by USFDA
Action taken against 694 manufacturing units since 2022: MinisterUSFDA approves Lupin drug for HIV-1 infection
Merck discontinues clinical development programs for vibostolimab, favezelimabMerck discontinues clinical development programs for vibostolimab, favezelimab
PM modi inaugrates medical devices plant19 green field projects commissioned under PLI scheme for medical devices
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantUSFDA inspection: Aurobindo Pharma arm Telangana facility gets 2 observations
Glenmark Pharma USA unveils Lacosamide Oral SolutionGlenmark Pharma USA unveils Lacosamide Oral Solution
USFDA Flags Sarfez Pharma for Misleading Promotion of Torsemide Drug SoaanzBoxed Warning: USFDA issues most serious warning on menopause medicine
Gilead Sciences, Kymera Therapeutics ink pact to develop novel oral molecular glue CDK2 degradersLupin Digital Health collaborate with Medicover Hospitals for post-discharge cardiac care
Eli Lilly Gets CDSCO Panel Nod for Ixekizumab Safety Label UpdateEli Lilly and Company gets CDSCO panel nod to import, market Tirzepatide Multiple Dose Pen
CDSCO Panel Nod To MSDs Sotatercept Label Change, Expands Prescribing Rights to CardiologistsMSD Pharmaceutical Gets CDSCO Panel Nod To study MK-1084
X